^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

PGR (Progesterone receptor)

i
Other names: PGR, Progesterone receptor, Nuclear receptor subfamily 3 group C member 3, NR3C3
1m
Concordance of Receptor Expression Status in the Primary Breast Tumor and in Breast Cancer Metastasized into the Brain: Analysis from an Indian Cohort Prospective Study (CTRI/2022/01/039599). (PubMed, Indian J Surg Oncol)
Present findings are from a small sample cohort and need further validation from a larger cohort. The online version contains supplementary material available at 10.1007/s13193-025-02427-0.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • PGR (Progesterone receptor)
|
HER-2 positive • HER-2 negative • HER-2 expression • ER negative
1m
Development and validation of a machine learning model to evaluate survival in patients with newly diagnosed breast cancer with liver metastasis. (PubMed, Front Oncol)
The calibration curves indicated good agreement and DCA confirmed the clinical utility of the model. The proposed nomogram demonstrated robust predictive performance for patients with breast cancer and liver metastases and may provide valuable prognostic information, pending further validation.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
1m
High Mammographic Density in Younger Women and Its Implications for Breast Cancer Subtypes. (PubMed, Int J Breast Cancer)
These underscore the relevance of age-related biological factors in shaping breast cancer characteristics. However, among Indonesian women over 45 years old, the proportion of high breast density remains remarkably high (65.6%), suggesting that factors beyond age-such as genetic, hormonal, or lifestyle influences-may contribute to the persistence of dense breast tissue in this population.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 expression • ER negative
1m
Ultrasound-Based AI in Predicting Hormone Receptor Status in Breast Cancer: Is "Digital Biopsy" Possible. (PubMed, J Imaging Inform Med)
This approach offers a promising, non-invasive alternative to traditional tissue sampling by enabling a "digital biopsy." Integrating these models into clinical workflows could reduce the diagnostic burden on patients and facilitate personalized treatment planning. However, further validation in larger, prospective cohorts is necessary.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
ER positive • HR positive
1m
High glucose promotes aggressive progression of PR-negative endometrial cancer via CD146. (PubMed, J Transl Med)
In summary, high glucose may promote the progression of PR-negative EC by downregulating CD146 expression and inducing EMT, suggesting that CD146 represents a promising therapeutic target for precision treatment strategies in EC, particularly in patients with concurrent glucose metabolism dysregulation.
Journal
|
PGR (Progesterone receptor) • MCAM (Melanoma Cell Adhesion Molecule) • TGFB1 (Transforming Growth Factor Beta 1)
1m
TBCRC026: Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer (clinicaltrials.gov)
P2, N=88, Active, not recruiting, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Trial completion date: Jun 2026 --> Jun 2027
Trial completion date
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 positive
|
Herceptin (trastuzumab) • Perjeta (pertuzumab)
1m
Long Non-Coding RNAs in Triple-Negative Breast Cancer: Emerging Drivers of Tumor Biology, Prognosis, and Drug Resistance. (PubMed, Crit Rev Oncol Hematol)
We discuss key lncRNAs implicated in TNBC pathogenesis and their potential as diagnostic biomarkers, prognostic indicators and therapeutic targets. By elucidating the complex interplay between lncRNAs and oncogenic pathways, this review underscores the promise of lncRNA-based strategies in improving TNBC management and patient outcomes.
Review • Journal
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 expression
1m
Enrollment open
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
1m
Quantification of estrogen receptor alpha and progesterone receptor expression in normal, dysplastic, and oral squamous cell carcinoma tissues in South Indian population: A cross-sectional study. (PubMed, Indian J Pathol Microbiol)
The precise role of hormones in OSCC has been less explored in the literature. Therefore, the significant expression of ERα and PR observed in dysplastic and OSCC groups in this study may elucidate their roles in tumor development and progression.
Observational data • Journal
|
ER (Estrogen receptor) • PGR (Progesterone receptor)
1m
Prediction of hormone receptor status in breast cancer brain metastases using an MRI-based multimodal deep learning framework. (PubMed, Front Hum Neurosci)
This study demonstrates the feasibility and clinical potential of non-invasive molecular profiling of BCBMs using a multi-modal DL approach. These findings might offer a promising tool for treatment planning and patient management, reducing the need for invasive biopsies while enabling more accurate and comprehensive molecular characterization of brain metastases.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • PGR (Progesterone receptor)
1m
Dietary phytoestrogen intake and risk of receptor-defined breast cancer subtypes: a prospective analysis of the PLCO Cancer Screening Trial cohort. (PubMed, Cancer Epidemiol Biomarkers Prev)
These findings suggest that associations between dietary phytoestrogen intake and breast cancer may vary across receptor-defined subtypes and highlight the need for replication using biomarker-based measures and populations with higher exposure levels.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 positive
1m
Enrollment closed
|
ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 positive • HR positive
|
Kadcyla (ado-trastuzumab emtansine) • trastuzumab rezetecan (SHR-A1811)